Asset-Backed Securities Market to Reach $3360.39 Billion by 2029, Fueled by Robust Real Estate Activities and Regulatory Support

 

The asset-backed securities market size has witnessed strong growth from $2429.05 billion in 2024, poised to reach $2597.65 billion in 2025, a compound annual growth rate (CAGR) of 6.9%. This historic growth can be attributed to factors like the rise of securitization as a financial practice, economic stability and low-interest rate environment, growing mortgage market and housing demand, evolution of credit rating agencies, and the expansion of consumer credit markets.

The asset-backed securities market size is set to continue its robust growth through the next few years, reaching $3360.39 billion by 2029, a CAGR of 6.6%. The key drivers of this growth include supportive regulatory frameworks, demand for diversifiedInvestment portfolios, integration of real-time data in ABS valuation, the influence of digital assets and tokenization on ABS, increased emphasis on ESG factors, and shifting demographics and consumer behavior.

For more insights, grab your free sample of the Global Asset-Backed Securities Market Report at: https://www.thebusinessresearchcompany.com/sample.aspx?id=12508&type=smp

What Drives The Growth of The Asset-Backed Securities Market?
Real estate activities are playing a pivotal role in propelling the growth of the asset-backed securities market. Real estate, encompassing properties such as residential, commercial, and industrial buildings, heavily utilizes asset-backed securities to raise capital, manage risk, and improve liquidity. The homeownership rate in the US, for instance, rose from 65.90% in Q4 2022 to 66% in Q1 2023. Moreover, the number of homes for sale in December 2022 was 54.7% higher than in 2021, suggesting a robust real estate market contributing to the growth of the asset-backed securities market.

What Market Segments Does the Global Asset-Backed Securities Market Englobe?
1) By Type: Existing Assets, Future Cash Flow
2) By Application: Real Estate, Travel, Finance, Healthcare, Education
3) By Downstream Industry: Small And Medium Enterprises (SME), Large Enterprise

Want to learn more? Order your report now at: https://www.thebusinessresearchcompany.com/report/asset-backed-securities-global-market-report

Which Companies Are Influencing the Asset-Backed Securities Market?
Prominent companies operating in the asset-backed securities market include Bank of America Corporation, Citigroup Inc., Wells Fargo And Company, BNP Paribas, Morgan Stanley, HSBC Group, Goldman Sachs Group Inc., ING Group, Capital One Financial Corporation, UBS Group AG, Barclays Plc., Deutsche Bank AG, Societe Generale S.A., Mizuho Financial Group Inc., BlackRock Inc., Fidelity Investments, Credit Suisse Group AG, Manulife Financial Corporation, State Street Corporation, The Vanguard Group Inc., Franklin Templeton Investments, Janus Henderson, Aegon Asset Management, WisdomTree Inc., Conning Holdings Limited, Fitch Ratings Inc., Eaton Vance Corp.

What Trends Are Shaping The Asset-Backed Securities Market Landscape?
Innovations like the launch of asset-backed securities funds are emerging as trends in the asset-backed securities market. For instance, Morgan Stanley launched a floating-rate global asset-backed securities fund in March 2023. This innovative solution exposes investors to a diversified portfolio of high-quality, floating-rate asset-backed securities. It invests in various maturities while focusing on high-quality assets with strong credit ratings.

What's the Regional Outlook For The Asset-Backed Securities Market?
In 2024, North America dominated the asset-backed securities market, with Asia-Pacific projected to be the fastest-growing region in the forecast period. The report covers regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Does The Comprehensive Asset-Backed Securities Market Report 2025 Offer?
The Asset-Backed Securities Market research report by The Business Research Company offers a global market size analysis, growth rate projections, regional shares, competitor analysis, detailed segments, trends, and opportunities. Asset-Backed Securities (ABS) refer to financial instruments backed by a pool of assets like loans, leases, or receivables. It is used to provide liquidity to lenders and diversify investment portfolios by allowing investors to gain exposure to the underlying assets.

Explore more valuable market insights with our exclusive report, available at: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12508

About The Business Research Company
The Business Research Company, with over 15000+ reports from 27 industries and 60+ geographies, has built a reputation for comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, unique insights from industry leaders, and in-depth secondary research, we strive to provide the information you need to stay ahead. Our leading product, The Global Market Model, offers a premier market intelligence platform with comprehensive, updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more